Streetbeat News

Earnings

TCRX

TScan Therapeutics reported ending Q3 with cash, cash equivalents, and marketable securities of $215.4M. This amount is expected to fund the company's operations into 2026.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:28 pm

TCRX

TScan Therapeutics (NASDAQ:TCRX) reported Q3 earnings per share (EPS) of $(0.24), beating the analyst consensus estimate of $(0.45) by 46.67%. However, the company's quarterly sales of $3.89 million missed the analyst consensus estimate of $4.09 million by 4.96%. Compared to the same period last year, the EPS increased by 64.18% and sales increased by 15.58%.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:28 pm

SHCR

Sharecare has projected its Q4 revenue to be between $111M-$113M. The company also maintains its 2023 revenue forecast of $452.5M-$460M.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:28 pm

MNPR

Monopar Therapeutics reported Q3 losses of $(0.14) per share, beating the analyst consensus estimate of $(0.17) by 17.65%. This is a 26.32% increase over losses from the same period last year. The company's cash, cash equivalents and short-term investments of $8.5M are estimated to fund its operations at least through November 2024.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:27 pm

IPSC

Century Therapeutics (NASDAQ:IPSC) reported Q3 earnings, missing estimated earnings by 7.84% with an EPS of $-0.55 versus an estimate of $-0.51. Revenue was down $2.08 million from the same period last year. Last quarter, the company also missed on EPS by $0.02, which was followed by a 4.91% drop in the share price the next day.

Portfolio Pulse from Benzinga Insights

November 09, 2023 | 12:25 pm

DIS

QQQ

SPY

The stock market's momentum appears to be waning with futures suggesting a mixed opening for Thursday. Earnings reports have generally been positive, with companies like Walt Disney Co. posting encouraging quarterly results. Bond yields have started to rise in anticipation of the IMF panel discussion, featuring Federal Reserve Chair Jerome Powell. Morgan Stanley's Lisa Shalett remains wary of a potential slowing in economic growth, the specter of sticky inflation, the overall market trend remaining sideways and uninspiring, and the stresses emerging in the high-yield or speculative grade credit.

Portfolio Pulse from Shanthi Rexaline

November 09, 2023 | 12:25 pm

OMGA

Omega Therapeutics (NASDAQ:OMGA) reported Q3 earnings, beating estimated earnings by 24.53% with an EPS of $-0.4 versus an estimate of $-0.53. Revenue was up $236 thousand from the same period last year. Last quarter, the company missed on EPS by $0.03, which was followed by a 2.42% increase in the share price the next day.

Portfolio Pulse from Benzinga Insights

November 09, 2023 | 12:25 pm

CABA

Cabaletta Bio (NASDAQ:CABA) reported its Q3 earnings, beating estimated earnings by 7.5% with an EPS of $-0.37 versus an estimate of $-0.4. However, revenue was down $0 from the same period last year. Last quarter, the company beat on EPS by $0.07, which was followed by an 11.0% increase in the share price the next day.

Portfolio Pulse from Benzinga Insights

November 09, 2023 | 12:25 pm

IMVT

Immunovant reported Q2 losses of $(0.45) per share, beating the analyst consensus estimate of $(0.48) by 6.25%. This is a 9.76% decrease over losses of $(0.41) per share from the same period last year. The company's pro forma cash and cash equivalent stands at $737M.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:24 pm

TDG

TransDigm Group Incorporated (TDG) has issued its fiscal 2024 guidance, expecting net sales to be in the range of $7.48 billion to $7.68 billion, up from $6.585 billion in fiscal 2023. The company also anticipates net income from continuing operations to be between $1.641 billion and $1.753 billion, and adjusted earnings per share to be between $31.00 and $32.94. The guidance excludes any impact from the pending acquisition of the Electron Device Business of CPI.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:23 pm